US › Healthcare

PAVmed Inc (PAVM)

US · Healthcare · Medical Devices

$5.04-8.36%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$22,000
Revenue YoY
+175.0%
Net profit
$-60,000
Profit YoY
-100.3%
EPS
$-1.17
EPS estimate
$-0.69
Net margin
-272.7%

EPS came in at -1.17 against a street estimate of -0.69 — a miss of 69.6%.

Key statistics

Market cap
$39.4M
Forward P/E
0.0
P/B
0.99
Book value
$5.71
EPS (TTM)
$-48.31
52-week high
$17.99
52-week low
$3.85
50-day MA
$5.43
200-day MA
$8.69
Beta
0.52

Analyst view

Analysts rate PAVmed Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $36.00.

Shareholding

Insiders
44.15%
Institutions
27.52%

Largest institutional holders

FundStake
Two Seas Capital LP6.45%
Vanguard Group Inc4.78%
First Manhattan Co. LLC0.33%
Geode Capital Management, LLC0.16%
Vanguard Capital Management, LLC0.08%
Vanguard Fiduciary Trust Co0.08%
BlackRock Inc0.03%
Atlantic Trust Group, LLC0.01%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for PAVmed Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.